Recursion Pharmaceuticals Inc (RXRX)
$3.50+1.60%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Promising drug trial data and FDA talks; cash burning fast — speculative until clinical proof lands.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United State…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- $1.8B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Recursion Pharmaceuticals Inc and 1,600+ UK and US stocks.
Start free